All In Biotech

Drug Trial Radar · NCT05712902

Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)

A Phase II, Single Arm, Multicenter Study to Evaluate Anti-tumor Activity, Safety, Tolerability and Pharmacokinetics of DZD9008 in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation

Last checked: Nov 20, 2026Latest source record: Dec 30, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

104

Actual

Start

Jul 19, 2021

Primary completion

Oct 17, 2022

Study completion Dec 31, 2025

Sponsor

Lead sponsor
Dizal PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Feb 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase II, single-arm, multi-center clinical study to evaluate the anti-tumor efficacy, safety, tolerability and pharmacokinetics of Sunvozertinib in participants with locally advanced or metastatic NSCLC carrying EGFR exon 20 insertion mutations whose disease has progressed on prior platinum-based chemotherapy

Conditions

  • Non-Small Cell Lung Cancer

Interventions

  • SunvozertinibDrug

    Daily dose of Sunvozertinib

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR) according to RECIST 1.1 by an Independent Review Committee (IRC)Time frame: From first dosing until disease progression or intolerable adverse events

Locations

33 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Cancer Hospital

    Beijing, China

  • Beijing Chest Hospital,Capital Medical University

    Beijing, China

  • Peking Union Medical College Hospital

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

  • Jilin Cancer Hospital

    Changchun, China

  • Hunan Cancer Hospital(The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University

    Changsha, China

  • West China Hospital of Sichuan University

    Chengdu, China

  • Army Medical Center of PLA

    Chongqing, China

  • Chongqing University Cancer Hospital(Chongqing Cancer Hospital)

    Chongqing, China

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, China

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, China

  • Hainan General Hospital

    Haikou, China

  • The First Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, China

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, China

  • Zhejiang Cancer Hospital (Cancer Hospital of the University of Chinese Academy of Sciences)

    Hangzhou, China

  • Harbin Medical University Cancer Hospital

    Harbin, China

  • The Second Hospital of Anhui Medical University

    Hefei, China

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, China

  • Jinan Central Hospital (Central Hospital Affiliated to Shandong First Medical University)

    Jinan, China

  • Yunnan Cancer Hospital

    Kunming, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, China

  • Fudan University Shanghai Cancer Center

    Shanghai, China

  • The First Hospital of China Medical University

    Shenyang, China

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, China

  • Shanxi Provincial Cancer Hospital

    Taiyuan, China

  • Tianjin Medical University Cancer Institute & Hospital

    Tianjin, China

  • The Affiliated Cancer Hospital of Xinjiang Medical University

    Ürümqi, China

  • Hubei Cancer Hospital

    Wuhan, China

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, China

  • Affiliated Cancer Hospital of Zhengzhou University(Henan Cancer Hospital)

    Zhengzhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.